IDEAL
Jump to navigation
Jump to search
The acronym
IDEAL
refers to multiple trials:
Incremental Decrease In Clinical Endpoints Through Aggressive Lipid Lowering
Incremental Decrease In Endpoints Through Aggressive Lipid Lowering Iressa Dose Evaluation In Advanced Lung Cancer
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
OK
Navigation menu
Personal tools
Log in
Request account
Namespaces
Page
Discussion
English
Views
Read
View source
View history
More
Search
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information